Implementations by Phenotype

Title Phenotypesort descending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Lipids Northwestern Implementation Lipids Northwestern University Case Only 92%
Lipids Implementation - Columbia Lipids Columbia University Case Only
PAD Marshfield Implementation Peripheral Arterial Disease - 2012 Marshfield Clinic Research Foundation Case Only 88% 97%
PAD Mayo Implementation Peripheral Arterial Disease - 2012 Mayo Clinic Case Only 91% 86%
PAD Northwestern Implementation Peripheral Arterial Disease - 2012 Northwestern University Case, Control 95%, 100% 100%, 82%
RBC Marshfield Implementation Red Blood Cell Indices Marshfield Clinic Research Foundation Case Only 96% 87%
RBC Mayo Implementation Red Blood Cell Indices Mayo Clinic Case Only 98% 94%
RBC Northwestern Implementation Red Blood Cell Indices Northwestern University Case Only 98% 91%
RBC Implementation - Columbia Red Blood Cell Indices Columbia University Case Only
T2D Marshfield Implementation Type 2 Diabetes Mellitus Marshfield Clinic Research Foundation Case, Control 99%, 98% 100%, 98%
T2D Northwestern Implementation Type 2 Diabetes Mellitus Northwestern University Case, Control 98%, 100% 100%, 100%
T2D Vanderbilt Implementation Type 2 Diabetes Mellitus Vanderbilt University Case, Control 100%, 100%
T2DM Implementation - Columbia Type 2 Diabetes Mellitus Columbia University Case, Control 293 478
WBC Marshfield Implementation White Blood Cell Indices Marshfield Clinic Research Foundation Case Only 90% 88%
WBC Northwestern Implementation White Blood Cell Indices Northwestern University Case Only 85% 100%
WBC Implementation - Columbia White Blood Cell Indices Columbia University Case Only
Resistant hypertension Implementation - Columbia Resistant hypertension Columbia University Case, Control 249 1,031
CDiff Implementation - Columbia Clostridium Difficile Colitis Columbia University Case, Control 107 139
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 100%, 100% 100%, 100%
VU E3 implementation Clostridium Difficile Colitis Vanderbilt University Medical Center Case, Control
Mayo Clinic eMERGE III Implementation Clostridium Difficile Colitis Mayo Clinic Case, Control 103 4,494
Harvard CDiff Clostridium Difficile Colitis Harvard Medical School Case Only 47 1,643
CHOP eM3 Clostridium Difficile Colitis CHOP Case, Control 104 214
NU C. diff. e3 new cases/ctls Clostridium Difficile Colitis Northwestern University Case, Control 75 348
CDiff NU implementation - May 2012 chart review Clostridium Difficile Colitis Northwestern University Case, Control 90%, 95% 95%

Pages